All In Biotech

Drug Trial Radar · NCT05166161

A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria

A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria

Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

247

Actual

Start

Feb 14, 2022

Primary completion

Jul 21, 2026

Study completion Jul 21, 2026

Sponsor

Lead sponsor
PTC TherapeuticsIndustry
Sponsor type
Industry
First posted
Dec 21, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to evaluate the long-term safety of PTC923 in participants with phenylketonuria, and to evaluate the changes from baseline in dietary phenylalanine (Phe)/protein consumption.

Conditions

  • Phenylketonuria

Interventions

  • PTC923Drug

    PTC923 powder for oral use will be suspended in water or apple juice prior to administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Treatment-Emergent Adverse Events (TEAEs)Time frame: Baseline up to end of study (up to 4 years)
  2. Change From Baseline in Dietary Phe/Protein Consumption at Week 26, Measured During Phe Tolerance Assessment PeriodTime frame: Baseline, Week 26

Locations

46 sites in 19 countries. Site status is shown where the registry gives one.

  • Children's Hospital Colorado

    Aurora, Colorado

  • UF College of Medicine, Department of Pediatrics Division of Genetics and Metabolism

    Gainesville, Florida

  • Indiana University School of Medicine Department of Medical and Molecular Genetics

    Indianapolis, Indiana

  • Boston Children's Hospital

    Boston, Massachusetts

  • Icahn School of Medicine at Mount Sinai (ISMMS)

    New York, New York

  • UPMC Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania

  • University of Utah

    Salt Lake City, Utah

  • The Queensland Children's Hospital

    South Brisbane, Brisbane, Australia

  • Westmead Hospital

    Westmead, New South Wales, Australia

  • PARC Clinical Research

    Adelaide, South Australia, Australia

  • Royal Children's Hospital

    Parkville, Victoria, Australia

  • Hospital de clinicas de Porto Alegre

    Porto Alegre, Rio Grande do Sul, Brazil

  • Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo

    Ribeirão Preto, São Paulo, Brazil

  • Metabolics and Genetics in Calgary (MAGIC) Clinic, Ltd.

    Calgary, Alberta, Canada

  • McMaster Children's Hospital Hamilton Health Sciences

    Hamilton, Ontario, Canada

  • The Hospital for Sick Children University of Toronto Adult Clinic: The Fred A Litwin Family Centre in Genetic Medicine University Health Network & Mt. Sinai Hospital

    Toronto, Ontario, Canada

  • Fakultní nemocnice Královské Vinohrady Klinika dětí a dorostu Ambulance pro léčbu PKU a HPA

    Prague, Czechia

  • Copenhagen University Hospital, Rigshospitalet

    Copenhagen, Denmark

  • Hôpital Necker-Enfants Malades - Centre de Référence des Maladies Héréditaires du Métabolisme

    Paris, France

  • Medical Genetics and Laboratory Diagnostics Center

    Tbilisi, Georgia

  • University Children's Hospital Hamburg Eppendorf (Kinder-UKE) Klinik für Kinder- und Jugendmedizin (Kinder-UKE)

    Hamburg, Germany

  • Universitätsklinikum Heidelberg / Zentrum für Kinder- und Jugendmedizin / Sektion für Neuropädiatrie & Stoffwechselmedizin

    Heidelberg, Germany

  • Universitätsklinikum Münster

    Münster, Germany

  • Department of Human Neuroscience, Child and Adolescent Neuropsychiatry, Policlinico Umberto I

    Rome, Italy

  • Azienda Ospedaliera-Universita Padova

    Padua, Veneto, Italy

  • PTC Clinical Site 1

    Multiple Locations, Japan

  • PTC Clinical Site 2

    Multiple Locations, Japan

  • PTC Clinical Site 3

    Multiple Locations, Japan

  • PanAmerican Clinical Research

    Guadalajara, Jalisco, Mexico

  • UMCG Beatrix Children's Hospital

    Groningen, Netherlands

  • Pomorski Uniwersytet Medyczny w Szczecinie Centrum Wsparcia Badań Klinicznych

    Szczecin, Poland

  • Centro Hospitalar Universitário Do Porto, Epe

    Porto, Portugal

  • CENTRO HOSPITALAR UNIVERSITÁRIO LISBOA NORTE Hospital de Santa Maria,

    Lisbon, Estremadura, Portugal

  • CENTRO HOSPITALAR UNIVERSITÁRIO LISBOA NORTE Hospital de Santa Maria

    Lisbon, Estremadura, Portugal

  • Univerzitetni klinicni center Ljubljana

    Ljubljana, Slovenia

  • Hospital Universitario Ramón y Cajal

    Madrid, Spain

  • Hospital Universitario Virgen del Rocío

    Seville, Spain

  • Hospital Sant Joan de Déu

    Barcelona, Esplugues de Llobregat, Spain

  • Çukurova Üniversitesi Tıp Fakültesi Balcalı Hastanesi

    Adana, Turkey (Türkiye)

  • Hacettepe University Medical Faculty

    Altındağ, Ankara, Turkey (Türkiye)

Showing 40 of 46 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.